BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36765179)

  • 1. Clinical trials of self-replicating RNA-based cancer vaccines.
    Morse MA; Crosby EJ; Force J; Osada T; Hobeika AC; Hartman ZC; Berglund P; Smith J; Lyerly HK
    Cancer Gene Ther; 2023 Jun; 30(6):803-811. PubMed ID: 36765179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccine strategies using self-replicating RNA viral platforms.
    Dailey GP; Crosby EJ; Hartman ZC
    Cancer Gene Ther; 2023 Jun; 30(6):794-802. PubMed ID: 35821284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.
    Velders MP; McElhiney S; Cassetti MC; Eiben GL; Higgins T; Kovacs GR; Elmishad AG; Kast WM; Smith LR
    Cancer Res; 2001 Nov; 61(21):7861-7. PubMed ID: 11691804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects.
    Osada T; Berglund P; Morse MA; Hubby B; Lewis W; Niedzwiecki D; Yang XY; Hobeika A; Burnett B; Devi GR; Clay TM; Smith J; Kim Lyerly H
    Cancer Immunol Immunother; 2012 Nov; 61(11):1941-51. PubMed ID: 22488274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation self-replicating RNA vectors for vaccines and immunotherapies.
    Aliahmad P; Miyake-Stoner SJ; Geall AJ; Wang NS
    Cancer Gene Ther; 2023 Jun; 30(6):785-793. PubMed ID: 35194198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes.
    Cassetti MC; McElhiney SP; Shahabi V; Pullen JK; Le Poole IC; Eiben GL; Smith LR; Kast WM
    Vaccine; 2004 Jan; 22(3-4):520-7. PubMed ID: 14670335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.
    Gipson CL; Davis NL; Johnston RE; de Silva AM
    Vaccine; 2003 Sep; 21(25-26):3875-84. PubMed ID: 12922122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
    Pushko P; Bray M; Ludwig GV; Parker M; Schmaljohn A; Sanchez A; Jahrling PB; Smith JF
    Vaccine; 2000 Aug; 19(1):142-53. PubMed ID: 10924796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
    Agnihothram S; Menachery VD; Yount BL; Lindesmith LC; Scobey T; Whitmore A; Schäfer A; Heise MT; Baric RS
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alphavirus replicon particles as candidate HIV vaccines.
    Davis NL; West A; Reap E; MacDonald G; Collier M; Dryga S; Maughan M; Connell M; Walker C; McGrath K; Cecil C; Ping LH; Frelinger J; Olmsted R; Keith P; Swanstrom R; Williamson C; Johnson P; Montefiori D; Johnston RE
    IUBMB Life; 2002; 53(4-5):209-11. PubMed ID: 12120997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer.
    Slovin SF; Kehoe M; Durso R; Fernandez C; Olson W; Gao JP; Israel R; Scher HI; Morris S
    Vaccine; 2013 Jan; 31(6):943-9. PubMed ID: 23246260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphavirus vectors: development and potential therapeutic applications.
    Schlesinger S
    Expert Opin Biol Ther; 2001 Mar; 1(2):177-91. PubMed ID: 11727528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
    Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
    J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
    Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
    Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
    Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
    J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.
    Kim DY; Atasheva S; McAuley AJ; Plante JA; Frolova EI; Beasley DW; Frolov I
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10708-13. PubMed ID: 25002490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
    Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
    Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the non-structural protein coding region regulate gene expression from replicon RNAs derived from Venezuelan equine encephalitis virus.
    Lin G; Zhang Y
    Biotechnol Lett; 2023 Aug; 45(8):1029-1038. PubMed ID: 37266878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.